Psychiatric Credibility Takes a Major Nose Dive

The boom in psychiatry these days is the poisoning of our children (and nursing home residents) with powerful anti-psychotic medications. The New York Times has just reported on the investigation by Senator Charles Grassley (R-Iowa) into the money paid by Big Pharma to the key researchers in this field. It shows that the researchers who have been behind promoting massive off-label use of these powerful drugs to children were on the take from Big Pharma and hiding millions in “consulting fees.” This dramatic and illegal conflict of interest is behind the blatant misuse of these medications in our society – along with their staggering health care costs to taxpayers. This is fraud on the grandest scale imaginable, since Big Pharma is making close to 10 billion a year in fraud-based sales.

Senator Grassley is a one-man Big-Pharma wrecking crew – doing the work the FDA should be doing. The FDA refuses to expose almost any corruption because it is itself corrupt with the same types of conflicts of interest. The problem for Grassley is that once he has done the investigative work the FDA should be doing, he has no real power to fix anything. Since the FDA can’t stand Grassley, nothing much is ever done. It will be interesting to see how this plays out, as the crimes exposed by Grassley are significant – shaking Big Pharma at the core of its fraudulent machine.